ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,110Medicare Part D Prescriptions Filled, Including Refills

Rank: 292 out of 6645

$663K Total Retail Price of All Prescriptions

Rank: 719 out of 6645

413 Patients Receiving at Least One Drug in Part D
12%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 1,631 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 967 58 1 4
OMEPRAZOLE 964 81 2 6
SIMVASTATIN 951 78 3 1
ATENOLOL 701 67 4 8
LEVETIRACETAM 629 22 5 119
TRAZODONE HCL 550 51 6 60
CARBAMAZEPINE 489 25 10 7 224
METFORMIN HCL 437 61 8 7
RAMIPRIL 402 33 9 118
DIVALPROEX SODIUM 384 0 10 113
BENZTROPINE MESYLATE 327 15 R 11 188
RISPERIDONE 296 45 12 93
POLYETHYLENE GLYCOL 3350 290 33 13 121
METOPROLOL TARTRATE 281 27 14 13
LOSARTAN POTASSIUM 274 48 15 12
OLANZAPINE 229 0 16 140
ENALAPRIL MALEATE 217 34 17 75
CLONIDINE HCL 214 42 18 56
HYDROCHLOROTHIAZIDE 199 45 19 9
PHENYTOIN SODIUM EXTENDED 176 15 20 172
QUETIAPINE FUMARATE 168 0 21 101
PROPRANOLOL HCL 167 0 22 151
MEGESTROL ACETATE 165 16 R 23 104
METOCLOPRAMIDE HCL 160 40 24 120
DILANTIN 150 25 25 436
TRAMADOL HCL 146 11 26 30
SINGULAIR 136 14 27 76
FAMOTIDINE 136 0 27 33
ATORVASTATIN CALCIUM 132 12 29 10
FLUOCINONIDE 128 21 30 130
IBUPROFEN 127 12 31 42
AMLODIPINE BESYLATE 127 73 31 2
LAMOTRIGINE 126 0 33 284
PANTOPRAZOLE SODIUM 121 13 34 29
SEROQUEL 119 0 35 208
RANITIDINE HCL 118 12 36 51
FUROSEMIDE 115 25 37 11
TOPIRAMATE 113 0 38 255
GEMFIBROZIL 112 0 39 96
LISINOPRIL 111 26 40 3
ALENDRONATE SODIUM 108 0 41 14
DIOVAN 105 0 42 19
GABAPENTIN 103 0 43 18
OXCARBAZEPINE 102 0 44 416
OXYBUTYNIN CHLORIDE 102 0 44 129
DIVALPROEX SODIUM ER 98 12 46 273
LEVOFLOXACIN 94 22 47 83
PAROXETINE HCL 94 12 47 72
CEPHALEXIN 92 17 49 111
BACLOFEN 92 0 49 100
ABILIFY 91 0 51 204
LABETALOL HCL 86 0 52 226
HALOPERIDOL 85 0 53 303
MONTELUKAST SODIUM 83 0 54 128
GLYBURIDE 79 0 R 55 58
PROMETHAZINE VC 78 0 R 56 444
ECONAZOLE NITRATE 74 0 57 263
BENAZEPRIL HCL 73 38 58 21
POTASSIUM CHLORIDE 69 0 59 28
ZOLPIDEM TARTRATE 64 0 60 17
CELEBREX 62 23 61 54
HYDROXYZINE HCL 62 0 R 61 161
NEXIUM 58 22 63 40
DILTIAZEM HCL 58 11 63 351
KETOCONAZOLE 58 11 63 196
LACTULOSE 56 0 66 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.